Key facts
- This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Aug 2021, 17:01.
Daniel M. Junius - 10 Aug 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- Director
- Issuer ticker
- IDXX
- Reported as of
- 10 Aug 2021
- Net transaction value
- -$1,428,185
- SEC form
- 4
- Accepted by SEC
- 12 Aug 2021, 17:01:12 UTC
- Prior SEC filing
- 03 Aug 2021
- Next SEC filing
- 02 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 12 Aug 2021.
Change
- Previous filing in this sequence was filed on 03 Aug 2021.
- Current net transaction value: -$1,428,185.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $204,170
- Shares
- +2,402
- Change %
- +83%
- Price
- $85.00
- Shares after
- 5,298
- Date
- 10 Aug 2021
- Ownership
- Direct
IDXX
transaction
Common Stock
Sale
- Transaction value
- $1,632,355
- Shares
- -2,402
- Change %
- -45%
- Price
- $679.58
- Shares after
- 2,896
- Date
- 10 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Options Exercise
- Transaction value
- Shares
- -2,402
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 10 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,402
- Exercise price
- $85.00
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the weighted average price of the shares sold ranging from a low of $679.47 to a high of $680.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F2
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders.
Footnote F3
Not applicable.